The Patent Finder

Themis Bioscience GmbH

Also on record
Records under this name other than patents Themis Bioscience GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Themis Bioscience GmbH

PatentTitleStatus Expires Confidence
US 9,655,961Recombinant Measles Virus Expressing Chikungunya Virus Polypeptides and Their Applications
In force
 · High confidence
In forceHigh confidence
US 11,110,162Recombinant Zika Vaccines
In force
 · High confidence
In forceHigh confidence
US 10,894,079Chromatography Based Purification Strategies for Viruses
Lapsed on the fee record
Ended Jan 19, 2025 · High confidence
Lapsed on the fee recordEnded Jan 19, 2025High confidence
17/252,210Integrated Manufacturing and Chromatographic System for Virus Production
Abandoned
Abandoned Apr 9, 2024
AbandonedAbandoned Apr 9, 2024
17/418,197Norovirus Vaccines
Abandoned
Abandoned Dec 2, 2024
AbandonedAbandoned Dec 2, 2024
18/021,369Co-Stimulatory 4-1BBL Ectodomain Polypeptides for Immunomodulation
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited